A review of clinical efficacy, safety, new developments and adherence to allergen-specific immunotherapy in patients with allergic rhinitis caused by allergy to ragweed pollen (Ambrosia artemisiifolia)
Authors:
Open Access
- 1 February 2017
- journal article
- review article
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 11, 247-257
Abstract
Allergic rhinitis is a common health problem in both children and adults. The number of patients allergic to ragweed (Ambrosia artemisiifolia) is on the rise throughout Europe, having a significant negative impact on the patients’ and their family’s quality of life. Allergen-specific immunotherapy (AIT) has disease-modifying effects and can induce immune tolerance to allergens. Both subcutaneous immunotherapy and sublingual immunotherapy with ragweed extracts/preparations have clear positive clinical efficacy, especially over pharmacological treatment, even years after the treatment has ended. AIT also has very good safety profiles with extremely rare side effects, and the extracts/preparations used in AIT are commonly well tolerated by patients. However, patient adherence to treatment with AIT seems to be quite low, mostly due to the fact that treatment with AIT is relatively time-demanding and, moreover, due to patients not receiving adequate information and education about the treatment before it starts. AIT is undergoing innovations and improvements in clinical efficacy, safety and patient adherence, especially with new approaches using new adjuvants, recombinant or modified allergens, synthetic peptides, novel routes of administration (epidermal or intralymphatic), and new protocols, which might make AIT more acceptable for a wider range of patients and novel indications. Patient education and support (eg, recall systems) is one of the most important goals for AIT in the future, to further enhance treatment success.Keywords
This publication has 84 references indexed in Scilit:
- The long distance transport of airborne Ambrosia pollen to the UK and the Netherlands from Central and south EuropeInternational Journal of Biometeorology, 2016
- Prevalence of ragweed allergy in rural Geneva – a pilot studySwiss Medical Weekly, 2015
- Types of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory diseaseClinical and Translational Allergy, 2014
- Efficacy of allergen-specific immunotherapy for atopic dermatitis: A systematic review and meta-analysis of randomized controlled trialsJournal of Allergy and Clinical Immunology, 2013
- Mechanisms of allergen-specific immunotherapyJournal of Allergy and Clinical Immunology, 2007
- Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trialsAnnals of Allergy, Asthma & Immunology, 2006
- Sublingual immunotherapy: A comprehensive reviewJournal of Allergy and Clinical Immunology, 2006
- Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001Journal of Allergy and Clinical Immunology, 2004
- Aluminium‐induced granulomas after inaccurate intradermal hyposensitization injections of aluminium‐adsorbed depot preparationsAllergy, 2000
- Antihistamine premedication in specific cluster immunotherapy: A double-blind, placebo-controlled studyJournal of Allergy and Clinical Immunology, 1996